PE

Q4 2023 update: private equity deals in pharmaceutical in the US

In the US pharmaceutical industry, there were 31 private equity deals announced in Q4 2023, worth a total value of…

How did Private equity deals perform in pharmaceutical in Q4 2023?

In the global pharmaceutical industry, there were 66 private equity deals announced in Q4 2023, worth a total value of…

Q4 2023 update: private equity deals in pharmaceutical in China

In the Chinese pharmaceutical industry, there were 2 private equity deals announced in Q4 2023, worth a total value of…

Q4 2023 update: private equity deals in pharmaceutical in the UK

In the British pharmaceutical industry, there were 6 private equity deals announced in Q4 2023, worth a total value of…

Q4 2023 update: private equity deals in pharmaceutical in North America

In the North American pharmaceutical industry, there were 34 private equity deals announced in Q4 2023, worth a total value…

Q4 2023 update: private equity deals in pharmaceutical in Europe

In the European pharmaceutical industry, there were 21 private equity deals announced in Q4 2023, worth a total value of…

Q4 2023 update: private equity deals in pharmaceutical in Asia-Pacific

In the Asia-Pacific pharmaceutical industry, there were 10 private equity deals announced in Q4 2023, worth a total value of…

Q4 2023 update: private equity deals in pharmaceutical in India

In the Indian pharmaceutical industry, there were 3 private equity deals announced in Q4 2023, worth a total value of…

Q4 2023 update: orphan designated drugs related private equity activity in the pharmaceutical industry

Analysis of the key themes driving private equity deal activity reveals that orphan designated drugs accounted for 5 pharmaceutical deals…

Q4 2023 update: precision and personalized medicine related private equity activity in the pharmaceutical industry

Analysis of the key themes driving private equity deal activity reveals that precision and personalized medicine accounted for 2 pharmaceutical…